Cite
HARVARD Citation
Griffith, D. et al. (n.d.). 216. A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of the Beta-lactamase inhibitor Xeruborbactam Alone and in Combination Meropenem in Healthy Adult Subjects. Open forum infectious diseases. p. . [Online].